Optimizing Sedation and Analgesia in the ICU: Teamwork in Patient Care

Faculty & Disclosures

Barry W. Sigal, MD, FCCP
ICU Medical Director
Forsyth Medical Center
Winston-Salem, NC

Barry W. Sigal is a Pulmonologist/Intensivist in Winston-Salem, NC. He is the Medical Director of Cardiopulmonary Services and the Intensive Care Units at Forsyth Medical Center, a 900 bed tertiary care community facility. He has been involved in the development of numerous multidisciplinary protocols in the ICU ranging from glucose management to extubation and sepsis medications.

Dr. Sigal has a BS in Biochemistry from the University of Georgia and a MD degree from the Medical College of Georgia. His Internal Medicine, Pulmonary and Critical Care training occurred at the Medical College of Virginia. He has practiced medicine in Winston-Salem since 1987.

Dr. Sigal is a member of numerous professional groups and is active in both the Society of Critical Care Medicine and the American College of Chest Physicians.

Karen Sands MSN, CCRN, APRN-BC
ICU Nurse Practitioner
Forsyth Medical Center
Winston-Salem, NC

Karen Sands has worked in the critical care environment for the past 21 years. She received her BSN from the University of North Carolina at Wilmington in 1988. In 2000, she received her MSN and Adult Nurse Practitioner degree from the University of North Carolina at Greensboro. Functioning as an advanced practice nurse over the past 9 years, she has worked with the ICU intensivists to cover a 30-bed medical/surgical ICU at Forsyth Medical Center in Winston Salem, NC. She is actively involved in the SCCM and AACN.

In 2008 she opened her own business, Critical Care Learning Curves: Novice to Expert, that provides education to all disciplines on topics related to the critical care arena. Being chosen as one of the Great100 nurses in North Carolina was the highlight for 2008. Currently, she is serving on the SCCM Glycemic Management Task force whose purpose is to develop the guidelines for tight glycemic control in the critically ill patient. At the Annual SCCM Congress in 2009, she was elected to serve on the SCCM Nursing Section Steering Committee.

Faculty Disclosure

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation. The planners of this activity have no real or perceived financial relationships to disclose.
-	Dr. Barry Sigal has disclosed that he has served as a consultant or speaker for Hospira, Pfizer, GlaxoSmithKline, AstraZeneca, and Boehringer Ingelheim.
-	Karen Sands has disclosed that she has served as a consultant or speaker for Hospira.

Program Information

Return to Optimizing Sedation and Analgesia in the ICU: Teamwork in Patient Care

The material presented here does not reflect the views of Pharmacy Choice, Inc., RxSchool, Hospira, or ProCE, Inc. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.